MNTL News

News
all
press releases
Wells Fargo began coverage on five biotech stocks on Monday, with only Compass Pathways receiving an ‘Equal-Weight’ rating while the rest received ‘Overweight’ ratings.
Stocktwits

Advertisement|Remove ads.